Get the Stockscreener App
3.41
2.40%
0.08
After Hours:
3.41
Creative Medical Technology Holdings Inc stock is traded at $3.41, with a volume of 12,889.
It is up +2.40% in the last 24 hours and down -2.57% over the past month.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
See More
Previous Close:
$3.33
Open:
$3.4
24h Volume:
12,889
Relative Volume:
0.14
Market Cap:
$8.80M
Revenue:
$102.80K
Net Income/Loss:
$-5.32M
P/E Ratio:
-0.8974
EPS:
-3.8
Net Cash Flow:
$-5.45M
1W Performance:
+0.89%
1M Performance:
-2.57%
6M Performance:
+55.00%
1Y Performance:
-19.82%
1-Day Range:
$3.30
$3.47
1-Week Range:
$3.22
$3.6899
52-Week Range:
$1.69
$6.90
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
3.41 | 8.59M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Is now a turning point for Creative Medical Technology Holdings Inc.2025 Support & Resistance & Low Risk Profit Maximizing Plans - newser.com
Live market analysis of Creative Medical Technology Holdings Inc.Weekly Market Summary & Weekly High Return Opportunities - newser.com
Why Creative Medical Technology Holdings Inc. is moving todayMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com
How Creative Medical Technology Holdings Inc. stock performs in weak economyJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
Will LEN.B stock remain on Wall Street radarMarket Activity Summary & Real-Time Stock Price Movement Reports - newser.com
Is Creative Medical Technology Holdings Inc. stock affected by interest rate hikesJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
What moving averages say about Creative Medical Technology Holdings Inc.Market Growth Summary & Risk Managed Trade Strategies - newser.com
Is Creative Medical Technology Holdings Inc. reversing from oversold territory2025 Price Action Summary & Expert Curated Trade Ideas - newser.com
Comparing Creative Medical Technology Holdings Inc. in custom built stock radarsQuarterly Market Review & Momentum Based Trading Signals - newser.com
Creative Medical Technology Holdings Inc Stock Analysis and ForecastTechnical Pattern Recognition & Get Tomorrow’s Winners Today With AI - earlytimes.in
Market reaction to Creative Medical Technology Holdings Inc.’s recent newsEarnings Miss & Fast Gain Stock Trading Tips - newser.com
How currency fluctuations impact Creative Medical Technology Holdings Inc. stockInflation Watch & Technical Pattern Alert System - newser.com
Mergers & Acquisitions Tracker - Plastics News
Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldwide, and Path to 50 Approvals by 2040ResearchAndMarkets.com - Business Wire
Risk adjusted return profile for Creative Medical Technology Holdings Inc. analyzed - newser.com
Price action breakdown for Creative Medical Technology Holdings Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - newser.com
Type 1 Diabetes Pipeline Drugs Report 2025: Innovative Drug Developments and Ongoing Clinical Studies Uncovered - Barchart.com
Creative Medical Technology Holdings Congratulates Nobel Laureates and Highlights Recent Patents for ImmCelz™ Platform - Quiver Quantitative
Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs - MarketScreener
2 U.S. Patents for ImmCelz: Creative Medical advances supercharged Treg therapy for HF and T1D - Stock Titan
Is Creative Medical Technology Holdings Inc a good long term investmentEarnings Date Calendar & Start Your Free Trading Journey Today - earlytimes.in
Is Creative Medical Technology Holdings Inc. stock poised for growthWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Is ALLT a good long term investmentStock Buyback Announcements & Minimal Capital Trading - earlytimes.in
Pattern recognition hints at Creative Medical Technology Holdings Inc. upsideJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
Short interest data insights for Creative Medical Technology Holdings Inc.Market Weekly Review & Safe Capital Growth Tips - newser.com
Will New Partnerships Boost TMT (India) Ltd.’s OutlookMarket Liquidity Analysis & High Profit Growth Stocks - earlytimes.in
Why Hedge Funds Are Buying Gujarat Mineral Development Corporation Limited in YEARCapital Gains Strategies & Free Real-Time Trading Signals - earlytimes.in
The Pipeline for of iPSC-Derived Cell Therapeutics in 2025 - BioInformant
Is Quadrant Televentures Limited Stock Set to Outperform Its Peers in YEAREquity Performance Review & Machine Learning Stock Picks, Daily - earlytimes.in
Will PSA.PRH stock keep outperforming rivalsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Why C.H. Robinson Worldwide Inc. (CH1A) stock remains stableStop Loss & Expert Verified Movement Alerts - newser.com
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Creative Medical Technology Holdings Inc Stock (CELZ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Finger Michael H. | Director |
Feb 18 '25 |
Sale |
5.00 |
750 |
3,750 |
1,101 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):